Zatosetron
Zatosetron is a chemical compound that belongs to the class of serotonin receptor antagonists. It is primarily known for its potential use in the treatment of nausea and vomiting, particularly those induced by chemotherapy.
Mechanism of Action[edit]
Zatosetron functions by blocking the action of serotonin at the 5-HT3 receptors. These receptors are found in the central nervous system and the gastrointestinal tract. By inhibiting these receptors, zatosetron can prevent the activation of the vomiting reflex, which is often triggered by the release of serotonin during chemotherapy.
Clinical Use[edit]
Zatosetron has been studied for its effectiveness in managing chemotherapy-induced nausea and vomiting (CINV). It is considered to be part of the class of drugs known as 5-HT3 receptor antagonists, which also includes other medications like ondansetron and granisetron.
Side Effects[edit]
Common side effects of zatosetron may include headache, constipation, and dizziness. As with other 5-HT3 receptor antagonists, there is also a risk of QT interval prolongation, which can lead to serious cardiac arrhythmias.
Pharmacokinetics[edit]
The pharmacokinetics of zatosetron involve its absorption, distribution, metabolism, and excretion. It is typically administered orally or via intravenous injection. The drug is metabolized in the liver and excreted primarily through the kidneys.
Research and Development[edit]
Zatosetron is still under investigation, and its use is not as widespread as other 5-HT3 receptor antagonists. Ongoing research aims to better understand its efficacy and safety profile in various patient populations.
See Also[edit]
- Serotonin
- 5-HT3 receptor antagonist
- Chemotherapy-induced nausea and vomiting
- Ondansetron
- Granisetron
References[edit]
External Links[edit]
-
 | This medical article is a stub. You can help WikiMD by expanding the page. |
